Liposome Drug Delivery Market Size

Liposome Drug Delivery Market size was over USD 5.46 Billion in 2023 and is likely to exceed USD 17.14 Billion by the end of 2036, growing at over 9.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of liposome drug delivery is evaluated at USD 5.91 Billion. The growth of this market can be attributed to the growing demand for effective and efficient therapeutics considering the growing cases of chronic disease all over the world. As a result, drugs are encapsulated into liposomes for effective delivery. According to World Health Organization, 41 million people lose their life owing to chronic disease every year which is equivalent to 74% of death globally.

Increasing advances in liposomal drug delivery methods owing to new investments and ongoing R&D activities, product launches, mergers and acquisitions, and collaborations among major market players, are driving the growth of liposomal drug delivery expected to drive further growth of the market.

Moreover, various government authorities have been seen offering funds and investments for the research and development activities of the liposome drug delivery market. For instance, in 2019, the NIH awarded researchers at the University of Massachusetts Amherst a USD 1.7 million grant to develop new liposome-based vaccine delivery systems.